Kerala Ayurveda Ltd.
Fundamentals
- Market cap
- ₹243 cr
- ROE
- 0.00%
- Debt / equity
- 6.95
- 52-week range
- 150.00 — 625.00
Company snapshot
Kerala Ayurveda Ltd.
Pharmaceuticals
₹275 cr
Latest quarter · Dec 2025
Sales₹33 cr
Net profit−₹5 cr
Op. margin−4.6%
EPS−₹3.69
Strength & growth
Debt / equity6.95×
Current ratio0.46×
Sales CAGR+15.1%
The timeline — 4 notes on Kerala Ayurveda Ltd.
May 2026
- 25 May 26 · 9:02 PM IST Lead Lead · Micro cap
Kerala Ayurveda targets ₹200 cr revenue by FY27
The nano-cap firm aims for 38% growth, banking on a 130% surge in e-products and a path to operating breakeven by January 2027.
- 25 May 26 · 8:07 PM IST Brief Brief · Earnings · Micro cap
Kerala Ayurveda's losses widened even as revenue grew
Standalone net loss hit ₹14.74 cr on 17.6% revenue growth; consolidated loss was ₹20.65 cr. The auditor flagged unprovided receivables from subsidiaries.
- 25 May 26 · 8:02 PM IST Brief Brief · Earnings · Micro cap
Kerala Ayurveda's losses widen even as revenue climbs
Standalone revenue grew 17.6% to ₹85.48 cr, but the net loss deepened to ₹14.74 cr. The auditor flagged unprovided subsidiary receivables.
- 25 May 26 · 7:46 PM IST Brief Brief · Earnings · Micro cap
Kerala Ayurveda's losses widen even as top line grows
Audited results for FY26 show standalone revenue up 17.6% but net loss deepening. The auditor flagged unprovided receivables from subsidiaries.